These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2564021)

  • 1. Lowered prevalence of infection with lactulose therapy in patients in long-term hospital care.
    McCutcheon J; Fulton JD
    J Hosp Infect; 1989 Jan; 13(1):81-6. PubMed ID: 2564021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactulose--a potential drug for the treatment of inflammatory bowel disease.
    Liao W; Cui XS; Jin XY; Florén CH
    Med Hypotheses; 1994 Oct; 43(4):234-8. PubMed ID: 7838007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of salmonella enteritis with special reference to lactulose (author's transl)].
    Knothe H; Knapp G; Meyer M; Polanetzki U; Weber G
    Infection; 1980; 8 Suppl 3():S 294-8. PubMed ID: 6997206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reduction of faecal incontinence by the use of "Duphalac" in geriatric patients.
    Ryan D; Wilson A; Muir TS; Judge TG
    Curr Med Res Opin; 1974; 2(6):329-33. PubMed ID: 4448099
    [No Abstract]   [Full Text] [Related]  

  • 7. Lactulose: a drug in search of a modus operandi.
    Conn HO
    Gastroenterology; 1978 Mar; 74(3):624-6. PubMed ID: 24572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific features of nosocomial infections in the elderly at a general hospital center. 5 surveys of annual prevalence].
    Eveillard M; Pisante L; Mangeol A; Dolo E; Guet L; Huang M; Viguier-Leroux P; Quenon JL; Fauvelle F
    Pathol Biol (Paris); 1998 Dec; 46(10):741-9. PubMed ID: 9922990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric faecal incontinence-a drug trial conducted by nurses.
    Wilson A; Muir TS
    Nurs Mirror Midwives J; 1975 Apr; 140(16):50-2. PubMed ID: 1093150
    [No Abstract]   [Full Text] [Related]  

  • 10. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nosocomial urinary stent infection at the urology service of the Cocody University Hospital Center].
    Konan PG; Manzan K; Dekou A; Djedje Mady A; Yao Dje C
    Dakar Med; 1999; 44(2):186-9. PubMed ID: 11957281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term effect of lactulose therapy in patients with chronic renal failure.
    Miura M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1989 Mar; 14(1):29-34. PubMed ID: 2699952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactulose syrup assessed in a double-blind study of elderly constipated patients.
    Sanders JF
    J Am Geriatr Soc; 1978 May; 26(5):236-9. PubMed ID: 346631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catheter-associated urinary tract infections: epidemiology and prevention].
    Esposito S; Noviello S; Leone S
    Infez Med; 2008 Sep; 16(3):130-43. PubMed ID: 18843210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of constipation in terminally ill patients.
    Crowther AG
    J Int Med Res; 1978; 6(4):348-50. PubMed ID: 689292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract infections--a survey.
    Fanning C; Schlech WF; MacDonald MS; LeFort-Jost S
    Can J Infect Control; 1991; 6(3):68-73. PubMed ID: 1824285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constipation in long-stay elderly patients: its treatment and prevention by lactulose, poloxalkol-dihydroxyanthroquinolone and phosphate enemas.
    Brocklehurst JC; Kirkland JL; Martin J; Ashford J
    Gerontology; 1983; 29(3):181-4. PubMed ID: 6852545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled comparison of nalidixic acid or lactulose with placebo in shigellosis.
    Hansson HB; Barkenius G; Cronberg S; Juhlin I
    Scand J Infect Dis; 1981; 13(3):191-3. PubMed ID: 7031858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL; Fresard KM; Lally BR
    Gastroenterology; 1982 Feb; 82(2):213-7. PubMed ID: 7054022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.